Naoko Hosono

Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML

Alexander E. Perl, Giovanni Martinelli, Jörge E. Cortes et al. · New England Journal of Medicine · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms

Chantana Polprasert, Isabell Schulze, Mikkael A. Sekeres et al. · Cancer Cell · 2015 · 435 citations · Full text

Veterinary Medicine, Genetics, Molecular Genetics +14

Dynamics of clonal evolution in myelodysplastic syndromes

Hideki Makishima, Tetsuichi Yoshizato, Kenichi Yoshida et al. · Nature Genetics · 2016 · 423 citations · Full text

Life Sciences, Genetics, Hematology +13

STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients

Andrés Jerez, Michael J. Clemente, Hideki Makishima et al. · Blood · 2013 · 160 citations · Full text

Life Sciences, Genetics, Hematology +11

Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria

Wenyi Shen, Michael J. Clemente, Naoko Hosono et al. · Journal of Clinical Investigation · 2014 · 140 citations · Full text

Life Sciences, Genetics, Hematology +14